CEP55 and neuroblastoma: Consistently, in the SEQC‐RPM‐seqcnb1 dataset, high DDX21 (Fig. 6G) or CEP55 (Fig. 6H) mRNA expression in the subset of 92 MYCN‐amplified neuroblastoma patients also correlated with poorer patient survival.